189 related articles for article (PubMed ID: 1324274)
1. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
van Vliet AA; Hackeng WH; Donker AJ; Meuwissen SG
J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Jolobe OM
J Hepatol; 1993 Sep; 19(2):321-2. PubMed ID: 8301072
[No Abstract] [Full Text] [Related]
3. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
Brunkhorst R; Wrenger E; Kühn K; Schmidt FW; Koch K
Klin Wochenschr; 1989 Aug; 67(15):774-83. PubMed ID: 2671477
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
[TBL] [Abstract][Full Text] [Related]
5. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM
Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047
[TBL] [Abstract][Full Text] [Related]
6. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
Eur Heart J; 1991 Aug; 12(8):924-7. PubMed ID: 1915430
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with IVCS and gross oedema and ascites with diuretic combination and ACE-inhibitors: relation to baseline PRA and PAC.
Van Vliet AA; Kröger R; Dubbelman R; Ten Bokkel-Huinink WW
Neth J Med; 1995 Feb; 46(2):62-72. PubMed ID: 7885524
[TBL] [Abstract][Full Text] [Related]
8. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
[TBL] [Abstract][Full Text] [Related]
9. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
Good JM; Brady AJ; Noormohamed FH; Oakley CM; Cleland JG
Circulation; 1994 Jul; 90(1):220-4. PubMed ID: 8026000
[TBL] [Abstract][Full Text] [Related]
10. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
11. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Jespersen B; Jensen L; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
[TBL] [Abstract][Full Text] [Related]
13. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
[TBL] [Abstract][Full Text] [Related]
14. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
15. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Gentile S; Bologna E; Terracina D; Angelico M
Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
17. Acute tolerance to furosemide. Pretreatment with captopril or prazosin does not influence diuresis and natriuresis.
Kron BG; Sjöström PA; Karlberg BE; Odlind BG
Scand J Urol Nephrol; 1994 Dec; 28(4):337-44. PubMed ID: 7886407
[TBL] [Abstract][Full Text] [Related]
18. Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism.
Chan R; Sealey JE; Michelis MF; Swan A; Pfaffle AE; Devita MV; Zabetakis PM
J Lab Clin Med; 1998 Sep; 132(3):229-35. PubMed ID: 9735929
[TBL] [Abstract][Full Text] [Related]
19. [Aldosterone and renin in liver cirrhosis with ascites].
Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
[TBL] [Abstract][Full Text] [Related]
20. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.
Wilcox CS; Guzman NJ; Mitch WE; Kelly RA; Maroni BJ; Souney PF; Rayment CM; Braun L; Colucci R; Loon NR
Kidney Int; 1987 Jan; 31(1):135-41. PubMed ID: 3550214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
